FDA Approves At-Home Self-Collection Device for Cervical Cancer Screening

1. Teal Wand™ is a newly FDA-approved at-home cervical cancer screening device.

2. Targets women aged 25 to 65 years at average risk of cervical cancer.

3. The approval was supported by the SELF-CERV study, which determined the device had equivalent performance to clinician-collected samples.

4. A comprehensive telehealth service and flexible payment options provided by Teal Health also aim to improve screening adherence.

5. Rollout starts in June, with a goal on eventually expanding nationwide.

Source: Teal Health